Aeterna Zentaris (TSE:AEZS) has released an update.
Aeterna Zentaris Inc. and Ceapro Inc. have officially completed their merger, creating a more diversified biopharmaceutical company poised to drive value and accelerate product development. This merger is expected to provide a stable cash flow, an extensive product pipeline, and enhanced R&D capabilities. The combined company, which will soon announce a new name, aims to leverage its expanded resources for strategic growth and long-term sustainability.
For further insights into TSE:AEZS stock, check out TipRanks’ Stock Analysis page.
